MarketInOut Stock Screener Log In | Sign Up

Venus Medtech Hangzhou Inc

HKSE • Healthcare • Medical Devices • Quote as of 10/30/2026
Venus Medtech Hangzhou Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeHKSE
Market Capitalization451.03 mln
Float437 mln
Earnings Date04/01/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.49
Borderline

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-179%
Severely loss-making

ROE

-25.74
Deeply negative

Business Description

Founded in 2009 and based in Hangzhou, China, Venus Medtech develops and sells a range of artificial heart valves and related medical devices for patients in China and around the world. The company's core products are designed to replace or repair damaged heart valves without open-heart surgery, addressing conditions affecting the aortic, pulmonary, mitral, and tricuspid valves. Venus Medtech also works on treatments for high blood pressure and offers supporting tools used during valve procedures.

Key Fundamentals

EPS-1.18
ROE-25.74
RPS0.69
ROIC-16.72
ROA-17.54
Interest Cover-19.31
EBITDA, mln-413
EV / EBITDA-1.62
EV / EBIT-1.37
Revenue, mln285
EV / Revenue2.34

Quote Details

Last 0.98
Change 0 (0%)
Open 0.985
Volume 242,000
Turnover 237,160
Average Volume 364,998

Financial Ratios

Pre-Tax Profit Margin-179
Leverage Ratio1.46
Current Ratio1.30
Price / Book0.30
Price / Tangible Book2.61
Debt / Equity0.13
Price / Sales1.87

Financial Strength

Altman Z-Score-2.01
Piotroski F-Score 5 / 9
Beneish M-Score-2.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.85% 27 / 100   
1 Month -16.95% 22 / 100   
2 Months -12.5% 44 / 100   
6 Months -47.31% 15 / 100   
1 Year -64.1% 10 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog